皇家华人

header-logo
GettyImages-609179959-hero
Hematology and Oncology
Roy-Silverstein

Roy Silverstein, MD

Professor and Chair Emeritus, Department of Medicine; Associate Director, Medical Scientist Training Program; Senior Investigator, Versiti Blood Research Institute; Professor of Cell Biology and Physiology

Locations

  • 皇家华人
    Department of Medicine
    Division of Hematology and Oncology

Biography

Roy Silverstein, MD, is Professor and Chair Emeritus of Medicine at the 皇家华人 Division of Hematology and Oncology. He graduated from Emory University School of Medicine in 1979, and then completed his residency and fellowship in hematology and medical oncology at New York Hospital-Cornell Medical Center. Dr. Silverstein is board certified in Internal Medicine, Hematology, and Oncology.

Research Interests

Dr. Silverstein's current research interests include laboratory based translational research on the molecular, cellular, and genetic causes of common human vascular disorders, including thrombosis, angiogenesis, and atherosclerosis. His clinical interests include thrombosis, hemostasis, and myeloproliferative neoplasms. Dr. Silverstein has published over 200 articles which include papers in Blood, Nature Medicine, J. Clinical Invest, and J. Exp Med.

Publications

  • (Cuker A, Kunkle R, Bercovitz RS, Byrne M, Djulbegovic B, Haberichter SL, Holter-Chakrabarty J, Lottenberg R, Pai M, Rezende SM, Seftel MD, Silverstein RL, Terrell DR, Cheung MC.) Blood Adv. 2024 Jun 11;8(11):2960-2963 PMID: 38593461 PMCID: PMC11302374 SCOPUS ID: 2-s2.0-85196395496 04/09/2024

  • (Yang M, Silverstein RL.) Antioxidants (Basel). 2024 Jan 09;13(1) PMID: 38247507 PMCID: PMC10812781 01/22/2024

  • (Chen V, Zhang J, Chang J, Beg MA, Vick L, Wang D, Gupta A, Wang Y, Zhang Z, Dai W, Kim M, Song S, Pereira D, Zheng Z, Sodhi K, Shapiro JI, Silverstein RL, Malarkannan S, Chen Y.) Front Cardiovasc Med. 2024;11:1436865 PMID: 39156133 PMCID: PMC11327822 SCOPUS ID: 2-s2.0-85201434395 08/19/2024

  • (Dai W, Zhang H, Lund H, Zhang Z, Castleberry M, Rodriguez M, Kuriakose G, Gupta S, Lewandowska M, Powers HR, Valmiki S, Zhu J, Shapiro AD, Hussain MM, López JA, Sorci-Thomas MG, Silverstein RL, Ginsberg HN, Sahoo D, Tabas I, Zheng Z.) Science. 2023 Sep;381(6661):eadh5207 PMID: 37651538 PMCID: PMC10697821 SCOPUS ID: 2-s2.0-85169348601 08/31/2023

  • (Byrne M, Mattison R, Bercovitz R, Lottenberg R, Rezende SM, Silverstein R, Terrell D, Kunkle R, Smith D, Bollard C, Haberichter S, Holter-Chakrabarty J, Pai M, Cheung M, Cuker A, Seftel M, Djulbegovic B.) Blood Adv. 2023 Aug 22;7(16):4323-4326 PMID: 37186271 PMCID: PMC10424133 05/15/2023

  • (Huang W, Li R, Zhang J, Cheng Y, Ramakrishnan DP, Silverstein RL.) Transl Res. 2023 Apr;254:68-76 PMID: 36377115 PMCID: PMC10863465 SCOPUS ID: 2-s2.0-85143169438 11/16/2022

  • (Pillai SS, Pereira DG, Zhang J, Huang W, Beg MA, Knaack DA, de Souza Goncalves B, Sahoo D, Silverstein RL, Shapiro JI, Sodhi K, Chen Y.) Front Cardiovasc Med. 2023;10:1046495 PMID: 37180782 PMCID: PMC10174328 SCOPUS ID: 2-s2.0-85159873988 05/14/2023

  • (Zhang J, Chang J, Beg MA, Huang W, Zhao Y, Dai W, Wu X, Cui W, Pillai SS, Lakhani HV, Sodhi K, Shapiro JI, Sahoo D, Zheng Z, Silverstein RL, Chen Y.) iScience. 2022 Sep 16;25(9):104963 PMID: 36072548 PMCID: PMC9442361 SCOPUS ID: 2-s2.0-85137074779 09/09/2022

  • (Chen Y, Zhang J, Cui W, Silverstein RL.) J Exp Med. 2022 Jun 06;219(6) PMID: 35438721 PMCID: PMC9022290 SCOPUS ID: 2-s2.0-85128794972 04/20/2022

  • (Kim SY, Jeong SJ, Park JH, Cho W, Ahn YH, Choi YH, Oh GT, Silverstein RL, Park YM.) Front Cardiovasc Med. 2022;9:792717 PMID: 35656400 PMCID: PMC9152264 06/04/2022

  • (Jiang Y, Guo Y, Hao J, Guenter R, Lathia J, Beck AW, Hattaway R, Hurst D, Wang QJ, Liu Y, Cao Q, Krontiras H, Chen H, Silverstein R, Ren B.) Communications Biology. December 2021;4(1) SCOPUS ID: 2-s2.0-85108778647 12/01/2021

  • (Dai W, Lund H, Chen Y, Zhang J, Osinski K, Jones SZ, Kreuziger LB, López JA, Benjamin IJ, Silverstein RL, Zheng Z.) J Clin Lipidol. 2021;15(5):724-731 PMID: 34470719 PMCID: PMC8353976 SCOPUS ID: 2-s2.0-85114047849 09/03/2021

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.